We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEIS icon
801
Advanced Energy
AEIS
$10.1B
$785K ﹤0.01%
7,456
-97
-1% -$10.2K
TDY icon
802
Teledyne Technologies
TDY
$29.2B
$784K ﹤0.01%
1,792
+201
+13% +$83.3K
CNM icon
803
Core & Main
CNM
$7.93B
$781K ﹤0.01%
17,595
-10,070
-36% -$482K
MTCH icon
804
Match Group
MTCH
$9.19B
$781K ﹤0.01%
20,644
-17,945
-47% -$628K
SCCO icon
805
Southern Copper
SCCO
$138B
$779K ﹤0.01%
7,152
+169
+2% +$16.6K
FSS icon
806
Federal Signal
FSS
$6.82B
$778K ﹤0.01%
8,321
+244
+3% +$22.3K
AVTR icon
807
Avantor
AVTR
$9.82B
$770K ﹤0.01%
29,768
+19,491
+190% +$478K
FTS icon
808
Fortis
FTS
$29.3B
$768K ﹤0.01%
16,902
+124
+0.7% +$5.3K
VERX icon
809
Vertex
VERX
$2.16B
$761K ﹤0.01%
19,752
-1,635
-8% -$60.3K
GDX icon
810
VanEck Gold Miners ETF
GDX
$22.5B
$755K ﹤0.01%
18,957
+1,000
+6% +$37.9K
CCL icon
811
Carnival Corporation Ltd
CCL
$38.1B
$752K ﹤0.01%
40,675
+1,396
+4% +$23.6K
BBY icon
812
Best Buy
BBY
$19B
$745K ﹤0.01%
7,211
-2,633
-27% -$237K
IYF icon
813
iShares US Financials ETF
IYF
$4.65B
$744K ﹤0.01%
7,162
– –
ESE icon
814
ESCO Technologies
ESE
$7.77B
$743K ﹤0.01%
5,759
+52
+0.9% +$6.13K
SPXC icon
815
SPX Corp
SPXC
$9.39B
$738K ﹤0.01%
4,630
+1,200
+35% +$181K
ATR icon
816
AptarGroup
ATR
$8.69B
$734K ﹤0.01%
4,585
+104
+2% +$15.4K
VRNS icon
817
Varonis Systems
VRNS
$4.67B
$731K ﹤0.01%
12,942
-1,789
-12% -$94.1K
XLRE icon
818
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.72B
$730K ﹤0.01%
16,338
– –
VRSN icon
819
VeriSign
VRSN
$26.3B
$722K ﹤0.01%
3,799
-7,257
-66% -$1.31M
STVN icon
820
Stevanato
STVN
$5.57B
$719K ﹤0.01%
35,941
+4,050
+13% +$81.5K
CHKP icon
821
Check Point Software Technologies
CHKP
$14.3B
$718K ﹤0.01%
3,725
+130
+4% +$23.8K
LOAR icon
822
Loar Holdings
LOAR
$6.23B
$714K ﹤0.01%
9,575
-1,990
-17% -$132K
MZTI
823
The Marzetti Company
MZTI
$3.05B
$710K ﹤0.01%
4,023
+40
+1% +$7.36K
COCO icon
824
Vita Coco
COCO
$3.86B
$707K ﹤0.01%
24,965
+67
+0.3% +$1.78K
AVA icon
825
Avista
AVA
$3.43B
$697K ﹤0.01%
+17,995
New +$680K
31 32
33
34 35

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.